These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 28370521

  • 1. Efficacy comparison of adjuvants in PcrV vaccine against Pseudomonas aeruginosa pneumonia.
    Hamaoka S, Naito Y, Katoh H, Shimizu M, Kinoshita M, Akiyama K, Kainuma A, Moriyama K, Ishii KJ, Sawa T.
    Microbiol Immunol; 2017 Feb; 61(2):64-74. PubMed ID: 28370521
    [Abstract] [Full Text] [Related]

  • 2. The protective effects of nasal PcrV-CpG oligonucleotide vaccination against Pseudomonas aeruginosa pneumonia.
    Naito Y, Hamaoka S, Kinoshita M, Kainuma A, Shimizu M, Katoh H, Moriyama K, Ishii KJ, Sawa T.
    Microbiol Immunol; 2018 Dec; 62(12):774-785. PubMed ID: 30378708
    [Abstract] [Full Text] [Related]

  • 3. Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa.
    Sawa T, Ito E, Nguyen VH, Haight M.
    Hum Vaccin Immunother; 2014 Dec; 10(10):2843-52. PubMed ID: 25483637
    [Abstract] [Full Text] [Related]

  • 4. The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.
    Kinoshita M, Kato H, Yasumoto H, Shimizu M, Hamaoka S, Naito Y, Akiyama K, Moriyama K, Sawa T.
    Hum Vaccin Immunother; 2016 Nov; 12(11):2833-2846. PubMed ID: 27454613
    [Abstract] [Full Text] [Related]

  • 5. Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice.
    Moriyama K, Wiener-Kronish JP, Sawa T.
    Microbiol Immunol; 2009 Nov; 53(11):587-94. PubMed ID: 19903258
    [Abstract] [Full Text] [Related]

  • 6. Vaccination of mice with hybrid protein containing Exotoxin S and PcrV with adjuvants alum and MPL protects Pseudomonas aeruginosa infections.
    Asadi Karam MR, Badmasti F, Ahmadi K, Habibi M.
    Sci Rep; 2022 Jan 25; 12(1):1325. PubMed ID: 35079054
    [Abstract] [Full Text] [Related]

  • 7. A Live Salmonella Vaccine Delivering PcrV through the Type III Secretion System Protects against Pseudomonas aeruginosa.
    Aguilera-Herce J, García-Quintanilla M, Romero-Flores R, McConnell MJ, Ramos-Morales F.
    mSphere; 2019 Apr 17; 4(2):. PubMed ID: 30996108
    [Abstract] [Full Text] [Related]

  • 8. In-Silico Analysis and Protective Efficacy of the PcrV Recombinant Vaccine against Pseudomonas Aeruginosa in the Burned and PA-Infected BALB/c Mouse Model.
    Fakoor MH, Owlia P, Mousavi Gargari SL, Sabokbar A.
    Iran J Immunol; 2020 Jun 17; 17(2):121-136. PubMed ID: 32602466
    [Abstract] [Full Text] [Related]

  • 9. Protective effect of DNA vaccine encoding pseudomonas exotoxin A and PcrV against acute pulmonary P. aeruginosa Infection.
    Jiang M, Yao J, Feng G.
    PLoS One; 2014 Jun 17; 9(5):e96609. PubMed ID: 24788626
    [Abstract] [Full Text] [Related]

  • 10. Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumonia.
    Baker SM, Pociask D, Clements JD, McLachlan JB, Morici LA.
    Vaccine; 2019 Feb 04; 37(6):808-816. PubMed ID: 30638799
    [Abstract] [Full Text] [Related]

  • 11. Immunization with 3-oxododecanoyl-L-homoserine lactone-r-PcrV conjugate enhances survival of mice against lethal burn infections caused by Pseudomonas aeruginosa.
    Golpasha ID, Mousavi SF, Owlia P, Siadat SD, Irani S.
    Bosn J Basic Med Sci; 2015 May 25; 15(2):15-24. PubMed ID: 26042508
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-PcrV IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound models.
    Ranjbar M, Behrouz B, Norouzi F, Mousavi Gargari SL.
    Mol Immunol; 2019 Dec 25; 116():98-105. PubMed ID: 31634816
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Outer Membrane Vesicles Displaying a Heterologous PcrV-HitA Fusion Antigen Promote Protection against Pulmonary Pseudomonas aeruginosa Infection.
    Li P, Wang X, Sun X, Guan Z, Sun W.
    mSphere; 2021 Oct 27; 6(5):e0069921. PubMed ID: 34612675
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic administration of anti-PcrV F(ab')(2) in sepsis associated with Pseudomonas aeruginosa.
    Shime N, Sawa T, Fujimoto J, Faure K, Allmond LR, Karaca T, Swanson BL, Spack EG, Wiener-Kronish JP.
    J Immunol; 2001 Nov 15; 167(10):5880-6. PubMed ID: 11698464
    [Abstract] [Full Text] [Related]

  • 17. PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia.
    Schaefers MM, Duan B, Mizrahi B, Lu R, Reznor G, Kohane DS, Priebe GP.
    Vaccine; 2018 Nov 12; 36(46):6926-6932. PubMed ID: 30314911
    [Abstract] [Full Text] [Related]

  • 18. Protective effect of pilin protein with alum+naloxone adjuvant against acute pulmonary Pseudomonas aeruginosa infection.
    Banadkoki AZ, Keshavarzmehr M, Afshar Z, Aleyasin N, Fatemi MJ, Behrouz B, Hashemi FB.
    Biologicals; 2016 Sep 12; 44(5):367-73. PubMed ID: 27427517
    [Abstract] [Full Text] [Related]

  • 19. Multivalent DNA vaccine protects mice against pulmonary infection caused by Pseudomonas aeruginosa.
    Saha S, Takeshita F, Sasaki S, Matsuda T, Tanaka T, Tozuka M, Takase K, Matsumoto T, Okuda K, Ishii N, Yamaguchi K, Klinman DM, Xin KQ, Okuda K.
    Vaccine; 2006 Sep 11; 24(37-39):6240-9. PubMed ID: 16806598
    [Abstract] [Full Text] [Related]

  • 20. Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge.
    Neely AN, Holder IA, Wiener-Kronish JP, Sawa T.
    Burns; 2005 Mar 11; 31(2):153-8. PubMed ID: 15683685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.